Modulatory Effect of Probiotics on Gastric Mucosal IL-8,IFN-γ and IL-4,IL-10 Levels in Helicobacter pylori-infected C57BL/6 Mice

ZHAO Dong,XU Guifang,ZOU Xiaoping

DOI: https://doi.org/10.3969/j.issn.1008-7125.2012.05.004

2012-01-01

Abstract:Background:Probiotics has beneficial effects in the treatment of Helicobacter pylori(H.pylori) infection,however,the mechanisms are not fully understood.Aims:To evaluate the effect of probiotics(Lactobacilli,Bacillus bifidus,Enterococcus) on gastric mucosal IL-8,IFN-γ and IL-4,IL-10 levels in H.pylori-infected C57BL/6 mice,and to explore the therapeutic mechanism.Methods: A total of 32 C57BL/6 mice were infected with H.pylori to establish the gastritis model,and were randomly divided into normal control group,model group,standard triple therapy group and combination therapy group(standard triple therapy combined with probiotics).Four weeks after treatment,all the mice were sacrificed.Infection of H.pylori in gastric mucosa was detected by rapid urease test,Giemsa staining and bacterial culture.The histopathological changes in gastric mucosa were estimated by HE staining.The levels of IL-8,IFN-γ and IL-4,IL-10 in gastric mucosa were determined by ELISA.Results: Eradication rate of H.pylori infection in combination therapy group was significantly higher than that in standard triple therapy group(P<0.05).Gastric neutrophil infiltration,chronic inflammation score,levels of IL-8,IFN-γ were significantly lower in combination therapy group than those in model group and standard triple therapy group(P<0.05),but were significantly higher than those in normal control group(P<0.05).Levels of IL-4,IL-10 were significantly higher in combination therapy group than those in other 3 groups(P<0.05).Conclusions: Standard PPI-based triple therapy supplemented with probiotics can effectively increase the eradication rate of H.pylori and reduce levels of proinflammatory factors IL-8,IFN-γ and neutrophil infiltration.Furthermore,probiotics has the ability to promote Th2 immune response through increasing the anti-inflammatory factors IL-4 and IL-10.